Joe Horvat

Senior Vice President, U.S. Oncology Commercial


As Senior Vice President, U.S. Oncology, Joe is responsible for driving the commercialization of the U.S. oncology product portfolio.    

With more than 20 years of pharmaceutical and biotech industry experience, Joe is known for execution excellence and strong results while generating a high level of enthusiasm and engagement from team members and collaborators. He has achieved success across various marketing and sales management roles with in-depth knowledge spanning multiple therapeutic areas, brands, and geographies.

Joe joined EMD Serono in 2010 where he has since played a critical role in the development of the Company’s U.S. oncology sales structure and organization. As part of this, he created a strong culture and attracted talent that incrementally added to the success of the franchise and then set the foundation for the company’s launch of its first immuno-oncology product.    

Joe spent over a decade of his early career at Bristol-Myers Squibb where he held various marketing roles across several areas including cardiovascular and oncology.    

He graduated from the University of Alberta with a bachelor’s degree in Neuropsychology.


You have accessed, but for users from your part of the world, we originally designed the following web presence

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement